Promising markers for the risk and prognosis of gestational diabetes mellitus

Prokhorenko T.S.; Saprina T.V.; Budeeva S.V.

doi:https://doi.org/10.17116/terarkh2016884112-116

Close metadata

Recommended articles:

Association between the vitamin D level and depression in the elderly people in the European North of Russia. Russian Journal of Preventive Medicine. 2024;(12):107-113

Salivary minerals and caries experience among adolescents in Syktyvkar, Komi Republic. Stomatology. 2024;(6):48-54

Chronic inflammation in case of obesity-associated diseases. Russian Journal of Preventive Medicine. 2025;(1):115-121

Vitamin D role in oral cavity diseases. Stomatology. 2025;(1):81-86

Features of the course of induced pregnancy during the transfer of a thawed embryo in women with polycystic ovary syndrome. Russian Journal of Human Reproduction. 2025;(1):54-62

Modern aspects of gestational diabetes mellitus: definition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41

Nutrient status of follicular fluid and blood serum in women with infertility as a marker of embryo quality. Pilot study. Russian Journal of Human Reproduction. 2025;(2):17-27

Clinical efficacy of vitamin D in the prevention of osteoporosis and fractures in elderly patients. Russian Journal of Preventive Medicine. 2025;(5):103-110

Associations between salivary minerals concentrations and caries experience among 12-years old children in Syktyvkar, Komi Republic. Russian Journal of Stomatology. 2025;(2):34-38

Predictors of the need for insulin therapy in gestational diabetes mellitus and the relationship between the need for insulin and the condition of newborns. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):73-79

Abstract:

The review provides information on the molecular genetic mechanisms for the development gestational diabetes mellitus (GDM). It gives data on the genetic identity of GDM and type 2 diabetes mellitus and considers a role of some adipokines and incretin hormones in the development of GDM. There is evidence for the role of magnesium and vitamin D deficiencies in the pathogenesis of gestational carbohydrate metabolic disturbances.

Keywords:

gestational diabetes mellitus

genetic markers

adipokines

incretins

vitamin D

magnesium

Authors:

Prokhorenko T.S.

Kafedra éndokrinologii i diabetologii Sibirskogo gosudarstvennogo meditsinskogo universiteta, Tomsk

Saprina T.V.

GBOU VPO "Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava RF, Tomsk

Budeeva S.V.

Regional Perinatal Center, Tomsk, Russia

Close metadata

References:

Dedov I, Krasnopol'skiy V, Sukhikh G. Russian National Consensus Statement on gestational diabetes: diagnostics, treatment and postnatal care. Sakharnyi diabet. 2012;4:4-10. (In Russ.) doi:10.14341/2072-0351-5531.
Bondar' I, Malysheva A. Alterations in hemostasis associated with pregnancy in patients with glycemic disorders. Sakharnyi diabet. 2013;2:77-81. (In Russ.) doi:10.14341/2072-0351-3760.
Saprina T, Timokhina E, Vorozhtsova I. Glycated hemoglobin test: diagnostic difficulties in gestational diabetes. Sakharnyi diabet. 2012;4:63-68. (In Russ.) doi:10.14341/2072-0351-5540.
Abell SK, De Courten B, Boyle JA, Teede HJ. Inflammatory and Other Biomarkers: Role in Pathophysiology and Prediction of Gestational Diabetes Mellitus. Int J Mol Sci. 2015;16(6):13442-13473. doi:10.3390/ijms160613442.
Ametov A. The contribution of current investigations to understanding the nature of type 2 diabetes mellitus, and treatment perspectives. Terapevticheskii arkhiv. 2014;1:4-9. (In Russ.)
Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE. Diabetes Prevention Program Research Group. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774-4779. doi:10.1210/jc.2008-0772.
Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773-1779. doi:10.1016/s0140-6736(09)60731-5.
Alves L, Dutra S, Godoy Garcia Costa P, Ribeiro Velasco LF. Allele-Specifi c PCR Assay to Genotype SNP rs7903146 in TCF7L2 Gene for Rapid Screening of Diabetes Susceptibility. Arquivos Brasileiros de Endocrinologia & Metabologia. 2008;52(8):1362-1366. doi:10.1590/s0004-27302008000800026.
Liu Z, Habener JF. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic betacell proliferation. J Biol Chem. 2008;283(13):8723-8735. doi:10.1074/jbc.m706105200.
Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nature Genet. 2006;38(3):320-323. doi:10.1038/ng1732.
Tong Y, Lin Y, Zhang Y, Yang J, Liu H, Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet. 2009;10(15):1-25. doi:10.1186/1471-2350-10-15.
Luo YY, Wang HY, Han XY, Ren Q, Wang F, Zhang XY, Sun XQ, Zhou XH, Ji LN. Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. Diab Res Clin Pract. 2009;85(2):139-146. doi:10.1016/j.diabres.2009.04.024 .
Peng S, Zhu Y, Lu B, Xu F, Li X, Lai M. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121 174 subjects. Mutagenesis. 2012;28(1):25-37. doi:10.1093/mutage/ges048.
Kang S, Xie Z, Zhang D. Association of the rs7903146 polymorphism in transcription factor 7-like 2 (TCF7L2) gene with gestational diabetes mellitus: a meta-analysis. Gynecol Endocrinol. 2013;29(10):873-877. doi:10.3109/09513590.2013.813469.
Torekov SS, Ma L, Grarup N, Hartmann B, Hainerova IA, Kielgast U, Kissow H, Rosenkilde M, GIANT Consortium, Leb J, Witte DR, Jorgensen T, Sandbaek A, Lauritzen T, Madsen OD, Wang J, Linneberg A, Madsbad S, Holst JJ, Hansen T, Pedersen O. Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterized by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1. Diabetologia. 2011;54(11):2820-2831. doi:10.1007/s00125-011-2265-7.
Huopio H, Cederberg H. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol. 2013;169(3):291-297. doi:10.1530/eje-13-0286.
Miehle K, Holger S, Fasshauer M. Leptin, Adiponectin and other Adipokines in Gestational Diabetes Mellitus and Pre-eclampsia. Clin Endocrinol. 2012;76(1):2-11. doi:10.1111/j.1365-2265.2011.04234.x.
Petunina N, Kuzina I. The role of hormones of adipose tissue in the development pregnancy complications in obese women. Ozhirenie i metabolizm. 2013;1:3-8. (In Russ.) doi:10.14341/2071-8713-5063.
Catalano PM. Trying to understand gestational diabetes. Diabetic Med. 2014;31(3):273-281. doi:10.1111/dme.12381.
Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X. Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis. PLoS ONE. 2014;9(1):е87863. doi:10.1371/journal.pone.0087863.
Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519-525. doi:10.1097/01.aog.0000113621.53602.7a
Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91(10):4137-4143. doi:10.1210/jc.2006-0980.
Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(2):112-119. doi:10.2337/dc07-s202.
D’Anna R, Baviera G, Cannata ML, De Vivo A, Di Benedetto A, Corrado F. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes. Gynecol Obstet Investigat. 2007;64(2):65-68. doi:10.1159/000099149.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature Rev Immunol. 2011;11(2):85-97. doi:10.1038/nri2921.
Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metabolism Research and Reviews. 2007;23(2):135-140. doi:10.1002/dmrr.661.
Zavalza-Gomez AB, Anaya-Prado R, Rincon-Sanchez AR, Mora-Martinez JM. Adipokines and insulin resistance during pregnancy. Diabetes Res Clin Pract. 2008;80(1):8-15. doi:10.1016/j.diabres.2007.12.012.
Altinova AE, Toruner F, Bozkurt N, Bukan N, Karakoc A, Yetkin I, Ayvaz G, Cakir N, Arslan M. Circulating concentrations of adiponectin and tumor necrosis factor-alpha in gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(3):161-165. doi:10.1080/09513590701227960.
Cortelazzi D, Corbetta S, Ronzoni S, Pelle F, Marconi A, Cozzi V, Cetin I, Cortelazzi R, Beck-Peccoz P, Spada A. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin Endocrinol. 2007;66(3):447-453. doi:10.1111/j.1365-2265.2007.02761.x
Mazaki-Tovi S, Romero R, Vaisbuch E, Erez O, Mittal P, Chaiworapongsa T, Kim SK, Pacora P, Yeo L, Gotsch F, Dong Z, Yoon BH, Hassan SS, Kusanovic JP. Maternal serum adiponectin multimers in gestational diabetes. J Perinatal Med. 2009;37(6):637-650. doi:10.1515/jpm.2009.101.
Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Communications. 2002;290(3):1084-1089. doi:10.1006/bbrc.2001.6307.
Lain KY, Daftary AR, Ness RB, Roberts JM. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol. 2008;69(3):407-411. doi:10.1111/j.1365-2265.2008.03198.x.
Retnakaran R, Connelly PW, Maguire G, Sermer M, Zinman B, Hanley AJ. Decreased high-molecular-weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetes. Diabetic Med. 2007;24(3):245-252. doi:10.1111/j.1464-5491.2007.02077.x.
Saprina T, Timokhina Ye, Musina N, Prokhorenko T, Tashireva L, Goncharevich O. Pancreatic and extra-pancreatic effects of incretins and perspectives for studying enteroinsulin hormonal system during gestational disorder of carbohydrate metabolism. Byulleten' sibirskoi meditsiny. 2013;3:132-147. (In Russ.)
Nadkarni P, Chepurny OG, Holz GG. Regulation of Glucose Homeostasis by GLP-1. Progress in Molecular Biology and Translational Science. 2014;121:23-65. doi:10.1016/b978-0-12-800101-1.00002-8.
Cypryk K, Vilsboll T, Nadel I, Smyczynska J, Holst JJ, Lewinski A. Normal secretion of the incretin hormones glucose-dependent insulinotropic poly-peptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(1):58-62. doi:10.1080/09513590601137004.
Reyes-Lopez R, Perez-Luque E, Malacara JM. Metabolic, hormonal characteristics and genetic variants of TCF7L2 associated with development of gestational diabetes mellitus in Mexican women. Diabetes/Metabolism Research and Reviews. 2014;30(8):701-706. doi:10.1002/dmrr.2538.
Pacini G, Tura A, Winhofer Y, Kautzky-Willer A. Incretin Effect in Women with Former Gestational Diabeteswithin a Short Period after Delivery. Int J Endocrinol. 2012:1-4. doi:10.1155/2012/247392.
Arora C. Role of vitamin D in modulating gestational diabetes. Biopolymers and Cell. 2011;27(2):85-92. doi:10.7124/bc.000087.
Maltseva L, Vasileva E. New approaches to assessment of the role of vitamin D in reproductive health of women. Prakticheskaya meditsina. 2013;7:42-47. (In Russ.)
Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52(12):2951-2958. doi:10.2337/diabetes.52.12.2951.
Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proceed. 2011;86(1):50-60. doi:10.4065/mcp.2010.0567.
Wolf M, Sauk J, Shah A, Smirnakis KV, Jimenez-Kimble R, Ecker JL, Thandhani R. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care. 2004;27(1):21-27. doi:10.2337/diacare.27.1.21.
Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, Walker LS, Lammas DA, Raza K, Sansom DM. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9):5458-5467. doi:10.4049/jimmunol.0803217.
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporosis International. 2005;16(7):713-716. doi:10.1007/s00198-005-1867-7.
Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511-514. doi:10.1007/bf00404136.
Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnesium Res. 2004;17:126-136.
Yang SJ, Hwang SY, Baik SH, Lee KW, Nam MS, Park YS, Woo JT, Kim YS, Park S, Park So-Y, Yim CH, Yoon HK, Kim S-H. Serum Magnesium Level Is Associated with Type 2 Diabetes in Women with a History of Gestational Diabetes Mellitus: The Korea National Diabetes Program Study. J Korean Med Scie. 2014;29(1):84-89. doi:10.3346/jkms.2014.29.1.84.
Suchkov S, Rose N, Notkins A, Golubnichaia O, Herrath M, Legg M, Marshall T. Introduction to preventive and predictive medicine: past experience and future reality. Terapevticheskii arkhiv. 2012;8:81-85. (In Russ.)